Biotech Values

[quantumdot]

>And from a societal point of view will divert a lot of cash that payors shell out for high-priced biologics into less productive channels than currently is the case.<

You are not seriously using [the need for] economic rationalism in US healthcare to defend Genentech are you? They are the poster child for the unsustainable cost vs. benefit system the country finds itself in.